KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Non Operating Income (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Non Operating Income for 16 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Income rose 1719.18% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 145.63% increase, with the full-year FY2025 number at $1.8 million, up 141.76% from a year prior.
  • Non Operating Income was $1.2 million for Q4 2025 at Biolife Solutions, up from -$398000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $6.2 million in Q3 2021 to a low of -$5.7 million in Q4 2021.
  • A 5-year average of $1736.8 and a median of $147000.0 in 2023 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: skyrocketed 5430.97% in 2021, then plummeted 1207.55% in 2024.
  • Biolife Solutions' Non Operating Income stood at -$5.7 million in 2021, then soared by 103.05% to $174000.0 in 2022, then dropped by 15.52% to $147000.0 in 2023, then plummeted by 149.66% to -$73000.0 in 2024, then surged by 1719.18% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Non Operating Income are $1.2 million (Q4 2025), -$398000.0 (Q3 2025), and $247000.0 (Q2 2025).